Engage 2021, Princeton’s second annual innovation and entrepreneurship conference, will be held online Dec. 1 and 2. The conference, which is free and open to everyone, offers opportunities to learn about, and catalyze, the transformation of discoveries into innovations that benefit society — from biomedicine and clean energy to wireless, cryptocurrency and quantum computing.
An international team of particle physicists have paused their search for dark matter to focus on the needs of victims of the global pandemic — in particular, their need to breathe.
In severe cases, COVID-19 can lead to pneumonia requiring mechanical ventilation, but the world’s supply of ventilators has proven too small for the exponentially increasing demand.
All classes to move online, all undergraduates to remain off campus except those meeting specific criteria
Undergraduate students received the important message below on Wednesday, March 11 from Jill Dolan, Dean of the College, and W. Rochelle Calhoun, Vice President for Campus Life. The latest University updates related to COVID-19 are available on the University's coronavirus website.
Dear Princeton Undergraduate Students,
Mohamed Abou Donia is one of 15 recipients of an award from the Gordon and Betty Moore Foundation as part of the Symbiosis in Aquatic Systems Initiative investigator program.
Princeton President Christopher L. Eisgruber has been named an ROI-NJ Influencer of higher ed in the publication's Power List 2020.
Princeton faculty and student researchers make many discoveries that have the potential to address cancer, infectious disease, autism and other development disorders, and other medical, behavioral and health challenges.
Now, a collaboration with Rutgers University and the New Jersey Institute of Technology is making it easier and faster for Princeton's medical and health-related research to reach patients and the community.
Princeton professors Mark Braverman, Matt Weinberg and Anirudha Majumdar have been named recipients of Google AI's 2019 Faculty Research Awards.
Optimeos Life Sciences, a startup founded by two Princeton University faculty members, has reached agreements with six pharmaceutical companies to develop therapeutics using a Princeton-developed drug delivery technology. The collaborations have the potential to improve the effectiveness of medications for the treatment of diseases, ranging from cancer to diabetes.
Using sophisticated algorithms to explore regions of the genome whose roles in cancer have been largely uncharted, an international team of researchers has opened the door to a new understanding of the disease’s genetic origins.
